{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T07:57:09Z","timestamp":1783065429982,"version":"3.54.6"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Germline (likely-)pathogenic variants (PV) in <jats:italic>CDH1<\/jats:italic> predispose carriers to hereditary diffuse gastric cancer and lobular breast cancer. Previous studies from the United States suggest <jats:italic>CDH1<\/jats:italic> variant carriers have an increased risk for adenomas or sessile serrated lesions (SSL), yet data linking <jats:italic>CDH1<\/jats:italic> PVs and colorectal neoplasia are scarce. We aimed to investigate colonoscopy findings in <jats:italic>CDH1<\/jats:italic> PVs. Adults carrying a PV\/LPV in <jats:italic>CDH1<\/jats:italic> with \u2265\u20091 colonoscopy between 01\/01\/2004\u201312\/31\/2023 were included. Patients were sourced from the David G. Jagelman Inherited Colorectal Cancer Registries at Cleveland Clinic and the German Consortium for Familial Intestinal Cancer. 103 <jats:italic>CDH1<\/jats:italic> PV carriers were included. Most were female (66%) and white (93.1%). The median age at first colonoscopy was 47 years. The adenoma detection rate (ADR) was 29.4% (95% CI:19.9\u201341.1%) in the German cohort and 48.6% (95% CI: 33.0-64.4%) in the Cleveland cohort (<jats:italic>p<\/jats:italic>\u2009=\u20090.055) and significantly correlated with age (&lt;\u200945 years, 13.6% (95% CI: 6.40\u201326.7%); 45\u201349 years, 52.4% (95% CI: 32.4\u201371.7%); \u226550 years, 52.6% (95% CI: 37.3\u201367.5%); <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). The ADR in Cleveland was higher than the U.S. average ADR but the difference was not statistically significant (48.6% vs. 35.6%, <jats:italic>p<\/jats:italic>\u2009=\u20090.08), and the ADR in the German cohort (29.4%) was similar to the national German average risk screening cohort (31.3% in men, <jats:italic>p<\/jats:italic>\u2009=\u20090.84; 20.1% in women, <jats:italic>p<\/jats:italic>\u2009=\u20090.08). In our screening cohort with <jats:italic>CDH1<\/jats:italic> PV carriers, we demonstrated an ADR of 13.5% in individuals under 45 years, similar to the ADR in patients aged 25\u201340 years with a family history of CRC. Overall, SSL detection rate was 9.7%. Colorectal cancer was diagnosed in 3 patients (3.2%), 2\/3 with an early age of onset before the age of 50 years. This first international study provides preliminary evidence of a higher ADR in U.S. <jats:italic>CDH1<\/jats:italic> PV carriers compared to the general population, with a high number of adenomas detected before the age of 50. This may indicate an increased CRC risk that should be explored in larger studies.<\/jats:p>","DOI":"10.1007\/s10689-025-00466-8","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T07:45:57Z","timestamp":1746431157000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Colonoscopy findings in CDH1 carriers from a multicenter international study"],"prefix":"10.1007","volume":"24","author":[{"given":"Arjun","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"H\u00fcneburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bettz\u00fcge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Marwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Aretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Spier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ripperger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Redler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mykyta","family":"Kachanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander E.","family":"Volk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak B.","family":"Vangala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severin","family":"Daum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Holinski-Feder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Steinke-Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Bahlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lady Katherine","family":"MejiaPerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"O\u2019Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"LaGuardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Liska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Macaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Sommovilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Nattermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"key":"466_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","volume":"1","author":"S Hansford","year":"2015","unstructured":"Hansford S, Kaurah P, Li-Chang H et al (2015) Hereditary diffuse gastric cancer syndrome: Cdh1 mutations and beyond. JAMA Oncol 1:23\u201332","journal-title":"JAMA Oncol"},{"key":"466_CR2","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1053\/gast.2001.29611","volume":"121","author":"PDP Pharoah","year":"2001","unstructured":"Pharoah PDP, Guilford P, Caldas C (2001) Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 121:1348\u20131353","journal-title":"Gastroenterology"},{"key":"466_CR3","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/jmedgenet-2019-105991","volume":"56","author":"RM Xicola","year":"2019","unstructured":"Xicola RM, Li S, Rodriguez N et al (2019) Clinical features and cancer risk in families with pathogenic\u2009<\u2009em\u2009>\u2009CDH1\u2009variants irrespective of clinical criteria. J Med Genet 56:838\u2013843","journal-title":"J Med Genet"},{"key":"466_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.2024.10852","volume":"332","author":"CE Ryan","year":"2024","unstructured":"Ryan CE, Fasaye G-A, Gallanis AF et al (2024) Germline CDH1 variants and lifetime Cancer risk. JAMA 332:722\u2013729","journal-title":"JAMA"},{"key":"466_CR5","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41416-021-01673-7","volume":"126","author":"E Adib","year":"2022","unstructured":"Adib E, El Zarif T, Nassar AH et al (2022) CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. Br J Cancer 126:797\u2013803","journal-title":"Br J Cancer"},{"key":"466_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S10689-024-00421-Z\/TABLES\/4","volume":"11","author":"LK Mejia Perez","year":"2024","unstructured":"Mejia Perez LK, O\u2019Malley M, Chatterjee A et al (2024) Endoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH1. Fam Cancer. Published Online September 11:1\u201310. https:\/\/doi.org\/10.1007\/S10689-024-00421-Z\/TABLES\/4","journal-title":"Published Online September"},{"key":"466_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S1470-2045(22)00643-X","volume":"24","author":"J Garcia-Pelaez","year":"2023","unstructured":"Garcia-Pelaez J, Barbosa-Matos R, Lobo S et al (2023) Genotype-first approach to identify associations between <\u2009em\u2009>\u2009CDH1\u2009germline variants and cancer phenotypes: a multicentre study by the European reference network on genetic tumour risk syndromes. Lancet Oncol 24:91\u2013106","journal-title":"Lancet Oncol"},{"key":"466_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.gastha.2022.10.006","volume":"2","author":"M Passi","year":"2023","unstructured":"Passi M, Gamble LA, Samaranayake SG et al (2023) Association of CDH1 germline variants and Colon polyp phenotypes in patients with hereditary diffuse gastric Cancer. Gastro Hep Adv 2:244\u2013251","journal-title":"Gastro Hep Adv"},{"key":"466_CR9","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.14309\/ajg.0000000000001996","volume":"117","author":"PP Stanich","year":"2022","unstructured":"Stanich PP, Elgindi D, Stoffel E et al (2022) Colorectal neoplasia in CDH1 pathogenic variant carriers: A multicenter analysis. Official J Am Coll Gastroenterol| ACG 117:1877\u20131879","journal-title":"Official J Am Coll Gastroenterol| ACG"},{"issue":"12","key":"466_CR10","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.3390\/cancers12123726","volume":"12","author":"T Marwitz","year":"2020","unstructured":"Marwitz T, H\u00fcneburg R, Spier I et al (2020) Hereditary diffuse gastric cancer: A comparative cohort study according to pathogenic variant status. Cancers (Basel) 12(12):3726 Published 2020 Dec 11. https:\/\/doi.org\/10.3390\/cancers12123726","journal-title":"Cancers (Basel)"},{"key":"466_CR11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1053\/j.gastro.2021.09.028","volume":"162","author":"A Shaukat","year":"2022","unstructured":"Shaukat A, Rex DK, Shyne M et al (2022) Adenoma detection rates for 45- to 49-Year-Old screening population. Gastroenterology 162:957\u2013959e951","journal-title":"Gastroenterology"},{"key":"466_CR12","first-page":"806","volume":"117","author":"M Bilal","year":"2022","unstructured":"Bilal M, Holub J, Greenwald D et al (2022) Adenoma detection rates in 45\u201349-Year-Old persons undergoing screening colonoscopy: analysis from the GIQuIC registry. Official J Am Coll Gastroenterol| ACG 117:806\u2013808","journal-title":"Official J Am Coll Gastroenterol| ACG"},{"key":"466_CR13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1053\/j.gastro.2015.04.012","volume":"149","author":"H Brenner","year":"2015","unstructured":"Brenner H, Altenhofen L, Kretschmann J et al (2015) Trends in adenoma detection rates during the first 10 years of the German screening colonoscopy program. Gastroenterology 149:356\u2013366e351","journal-title":"Gastroenterology"},{"key":"466_CR14","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/path.5229","volume":"247","author":"L Valle","year":"2019","unstructured":"Valle L, Vilar E, Tavtigian SV et al (2019) Genetic predisposition to colorectal cancer: syndromes, genes, classification of genetic variants and implications for precision medicine. J Pathol 247:574\u2013588","journal-title":"J Pathol"},{"key":"466_CR15","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/genes14091677","volume":"14","author":"M Lepage","year":"2023","unstructured":"Lepage M, Uhrhammer N, Privat M et al (2023) Case series of 11 CDH1 families (47 Carriers) including incidental findings, signet ring cell Colon cancer and review of the literature. Genes 14:1677","journal-title":"Genes"},{"key":"466_CR16","first-page":"786","volume":"120","author":"A Crispin","year":"2023","unstructured":"Crispin A, Rehms R, Hoffmann S et al (2023) Colorectal Cancer screening for persons with a positive family history. Dtsch Arztebl Int 120:786\u2013792","journal-title":"Dtsch Arztebl Int"},{"key":"466_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S2468-1253(22)00090-5","volume":"7","author":"DEFWM van Toledo","year":"2022","unstructured":"van Toledo DEFWM, Ijspeert JEG, Bossuyt PMM et al (2022) Serrated polyp detection and risk of interval post-colonoscopy colorectal cancer: a population-based study. Lancet Gastroenterol Hepatol 7:747\u2013754","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"466_CR18","doi-asserted-by":"publisher","first-page":"E610","DOI":"10.1055\/a-1352-4095","volume":"09","author":"M Desai","year":"2021","unstructured":"Desai M, Anderson JC, Kaminski M et al (2021) Sessile serrated lesion detection rates during average risk screening colonoscopy: A systematic review and meta-analysis of the published literature. Endosc Int Open 09:E610\u2013E620","journal-title":"Endosc Int Open"},{"key":"466_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/hmg\/8.4.607","volume":"8","author":"FM Richards","year":"1999","unstructured":"Richards FM, McKee SA, Rajpar MH et al (1999) Germline E-cadherin gene (CDH1) mutations predispose to Familial gastric Cancer and colorectal Cancer. Hum Mol Genet 8:607\u2013610","journal-title":"Hum Mol Genet"},{"key":"466_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/gut.47.2.262","volume":"47","author":"HC Kim","year":"2000","unstructured":"Kim HC, Wheeler JMD, Kim JC et al (2000) The E-cadherin gene (<\u2009em\u2009>\u2009CDH1) variants T340A and L599V in gastric and colorectal cancer patients in Korea. Gut 47:262\u2013267","journal-title":"Gut"},{"key":"466_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.14309\/ajg.0000000000001548","volume":"117","author":"SG Patel","year":"2022","unstructured":"Patel SG, May FP, Anderson JC et al (2022) Updates on age to start and stop colorectal Cancer screening: recommendations from the U.S. Multi-Society task force on colorectal Cancer. Official J Am Coll Gastroenterol| ACG 117:57\u201369","journal-title":"Official J Am Coll Gastroenterol| ACG"},{"key":"466_CR22","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/jama.2021.6238","volume":"325","author":"UPST Force","year":"2021","unstructured":"Force UPST (2021) Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA 325:1965\u20131977","journal-title":"JAMA"},{"key":"466_CR23","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/jmedgenet-2015-103094","volume":"52","author":"RS van der Post","year":"2015","unstructured":"van der Post RS, Vogelaar IP, Carneiro F et al (2015) Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet 52:361\u2013374","journal-title":"J Med Genet"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00466-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:57:44Z","timestamp":1750913864000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00466-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00466-8","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]},"assertion":[{"value":"22 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Cleveland Clinic IRB #21-1129 and at seven centers of the German Consortium for Familial Intestinal Cancer (GCFIC; Bonn, Bochum, D\u00fcsseldorf, Hannover, Hamburg, M\u00fcnster, Berlin, M\u00fcnchen; central IRB approval No. 099\/15 Bonn).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study in Germany. For retrospective analysis, no written informed consent was needed in Cleveland.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"44"}}